CytRx Corporation Reports Second Quarter 2019 Financial Results

Author's Avatar
Aug 09, 2019
Article's Main Image

Licensee Orphazyme A/S Rapidly Completes Enrollment in Clinical Trials for Multiple Indications and Prepares for Regulatory Submissions

PR Newswire